Protective effects of ivermectin against ischemia-reperfusion-induced ovarian injury in rats
Frontiers in Pharmacology · 04.11.2026 · 17
DOI: 10.3389/fphar.2026.2003125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 04.11.2026. Verfasst von Nesrin Yilmaz und 7 weiteren Autor:innen. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Ovarian ischemia-reperfusion (I/R) injury induces severe tissue damage through oxidative stress and inflammation, and DNA damage. This study investigated the protective effects of short- and long-term ivermectin application against ovarian I/R injury in rats.
Methods
Twenty-four female Wistar albino rats were divided into four groups: sham operation (SOG), ovarian I/R (OIR), long-term ivermectin-applied I/R (LIOIR), and short-term ivermectin-applied I/R (SIOIR). Ovarian torsion was maintained for 3 h before detorsion. Ivermectin (2 mg/kg, orally) was administered for 3 or 6 days. Ovarian malondialdehyde (MDA), total glutathione (tGSH), superoxide dismutase (SOD), and catalase (CAT) were measured. Histopathological and immunohistochemical analyses of cyclooxygenase-1 (COX-1), cyclooxygenase-2 (COX-2), and 8-hydroxy-2′-deoxyguanosine (8-OHdG) were also performed.
Results
OIR increased MDA and reduced tGSH, SOD, and CAT. Three-day ivermectin pretreatment normalized oxidative stress marker levels to values comparable to those in the sham group, whereas six-day pretreatment provided no significant protection. Follicular degeneration was pronounced in OIR and LIOIR but markedly attenuated in SIOIR. Immunohistochemistry demonstrated preserved COX-1 expression and reduced COX-2 and 8-OHdG immunoreactivity following short-term ivermectin pretreatment.
Conclusion
Short-term ivermectin effectively protected ovarian tissue against experimental I/R injury by reducing oxidative stress, inflammation, and DNA damage, whereas prolonged pretreatment failed to provide comparable protection, supporting its therapeutic potential.
Zitieren
APA
Yilmaz, N., Bulut, S., Paltaci, S. I., Mammadov, R., Sarigul, C., Ozkaraca, M., Tebrizi, B., & Suleyman, H. (2026). Protective effects of ivermectin against ischemia-reperfusion-induced ovarian injury in rats. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.2003125
Vancouver
Yilmaz N, Bulut S, Paltaci SI, Mammadov R, Sarigul C, Ozkaraca M, et al. Protective effects of ivermectin against ischemia-reperfusion-induced ovarian injury in rats. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.2003125
BibTeX
@article{Yilmaz2026,
author = {Yilmaz, Nesrin and Bulut, Seval and Paltaci, Seyma Ilayda and Mammadov, Renad and Sarigul, Cengiz and Ozkaraca, Mustafa and Tebrizi, Behzat and Suleyman, Halis},
title = {Protective effects of ivermectin against ischemia-reperfusion-induced ovarian injury in rats},
journal = {Frontiers in Pharmacology},
year = {2026},
volume = {17},
doi = {10.3389/fphar.2026.2003125}
}
EUVIMED